Importer of Controlled Substances; Notice of Application, 65788-65789 [E9-29542]
Download as PDF
<![CDATA[
jlentini on DSKJ8SOYB1PROD with NOTICES
65788
Federal Register / Vol. 74, No. 237 / Friday, December 11, 2009 / Notices
Counsel (202–205–3091 or
william.gearhart@usitc.gov). The media
should contact Margaret O’Laughlin,
Office of External Relations (202–205–
1819 or margaret.olaughlin@usitc.gov).
Hearing-impaired individuals may
obtain information on this matter by
contacting the Commission’s TDD
terminal at 202–205–1810. General
information concerning the Commission
may also be obtained by accessing its
Internet server (https://www.usitc.gov).
Persons with mobility impairments who
will need special assistance in gaining
access to the Commission should
contact the Office of the Secretary at
202–205–2000.
Background: In his letter the USTR
requested, under the authority of section
332(g) of the Tariff Act of 1930, that the
Commission provide three reports
during the next 12 months relating to
small and medium-sized enterprises
(SMEs). In this notice the Commission
is instituting the third of three
investigations under section 332(g) for
the purpose of preparing the third
report, which is to be transmitted to the
USTR by October 6, 2010. The
Commission published notices of
institution of the first investigation,
investigation No. 332–508, in the
Federal Register of October 28, 2009 (74
FR 55581) and the second investigation,
investigation No. 332–509, in the
Federal Register of December 1, 2009
(74 FR 62812).
As requested, in the third report the
Commission will, to the extent possible:
1. Examine U.S. SMEs engaged in
providing services, including the
characteristics of firms that produce
tradable services, the growth in these
services exports, and the differences
between SME and large services
exporters;
2. Identify how data gaps might be
overcome to further enhance our
understanding of SMEs in services
sector exports;
3. For both goods and services
exports, identify trade barriers (nontariff
barriers and tariffs) that may
disproportionately affect SME export
performance, as well as possible
linkages between exporting and SME
performance; and
4. Provide insights on the degree to
which SMEs operate as multinationals,
as affiliate firms, or as contributors of
indirect exports to international trade
through sales to larger exporting firms.
The USTR requested that the
Commission deliver the second report
by October 6, 2010.
Public Hearing: The Commission will
hold a joint public hearing in
connection with this investigation and
investigation No. 332–509 at the U.S.
VerDate Nov<24>2008
17:33 Dec 10, 2009
Jkt 220001
International Trade Commission
Building, 500 E Street, SW.,
Washington, DC, beginning at 9:30 a.m.
on Tuesday, February 9, 2010 (and
continuing on February 10, 2010, if
needed). Requests to appear at the
public hearing should be filed with the
Secretary no later than 5:15 p.m.,
January 26, 2010, in accordance with
the requirements in the ‘‘Submissions’’
section below. Persons wishing to
appear should indicate in their request
to appear whether they plan to provide
testimony with respect to investigation
No. 332–509, investigation No. 332–510,
or both investigations. All pre-hearing
briefs and statements should be filed not
later than 5:15 p.m., January 28, 2010;
and all post-hearing briefs and
statements responding to matters raised
at the hearing should be filed not later
than 5:15 p.m., February 23, 2010. In the
event that, as of the close of business on
January 26, 2010, no witnesses are
scheduled to appear at the hearing, the
hearing will be canceled. Any person
interested in attending the hearing as an
observer or non-participant may call the
Office of the Secretary (202–205–2000)
after January 26, 2010, for information
concerning whether the hearing will be
held. The Commission is also
considering holding additional hearings
in Portland, Oregon and St. Louis,
Missouri. Notice of the time, date, and
place of those hearings will be
published at a later date.
Written Submissions: In lieu of or in
addition to participating in the hearing,
interested parties are invited to file
written submissions concerning this
investigation. All written submissions
should be addressed to the Secretary,
and all such submissions (other than
pre- and post-hearing briefs and
statements) should be received not later
than 5:15 p.m., May 28, 2010. All
written submissions must conform with
the provisions of section 201.8 of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.8). Section 201.8
requires that a signed original (or a copy
so designated) and fourteen (14) copies
of each document be filed. In the event
that confidential treatment of a
document is requested, at least four (4)
additional copies must be filed, in
which the confidential information
must be deleted (see the following
paragraph for further information
regarding confidential business
information). The Commission’s rules
authorize filing submissions with the
Secretary by facsimile or electronic
means only to the extent permitted by
section 201.8 of the rules (see Handbook
for Electronic Filing Procedures,
https://www.usitc.gov/secretary/
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
fed_reg_notices/rules/documents/
handbook_on_electronic_filing.pdf).
Persons with questions regarding
electronic filing should contact the
Office of the Secretary (202–205–2000).
Any submissions that contain
confidential business information must
also conform with the requirements of
section 201.6 of the Commission’s Rules
of Practice and Procedure (19 CFR
201.6). Section 201.6 of the rules
requires that the cover of the document
and the individual pages be clearly
marked as to whether they are the
‘‘confidential’’ or ‘‘non-confidential’’
version, and that the confidential
business information be clearly
identified by means of brackets. All
written submissions, except for
confidential business information, will
be made available for inspection by
interested parties.
In his request letter, the USTR stated
that his office intends to make the
Commission’s reports available to the
public in their entirety, and asked that
the Commission not include any
confidential business information or
national security classified information
in the reports that the Commission
transmits to his office. Any confidential
business information received by the
Commission in this investigation and
used in preparing this report will not be
published in a manner that would
reveal the operations of the firm
supplying the information.
By order of the Commission.
Issued: December 7, 2009.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E9–29518 Filed 12–10–09; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a regulation under 21 U.S.C.
952(a)(2), authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on October
20, 2009, Tocris Cookson, Inc., 16144
Westwoods Business Park, Ellisville,
Missouri 63021–4500, made application
E:\FR\FM\11DEN1.SGM
11DEN1
Federal Register / Vol. 74, No. 237 / Friday, December 11, 2009 / Notices
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,
5dimethoxyamphetamine.
(7391) ...........................................
3,
4Methylenedioxymethamphetamine.
(7405) ...........................................
Amphetamine (1100) ....................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Diprenorphine (9058) ...................
Fentanyl (9801) ............................
I
I
I
17:33 Dec 10, 2009
DEPARTMENT OF JUSTICE
Dated: December 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–29542 Filed 12–10–09; 8:45 am]
Office of Justice Programs
BILLING CODE 4410–09–P
I
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
II
II
II
II
II
Jkt 220001
[OJP (NIJ) Docket No. 1510]
Vehicular Digital Multimedia Evidence
Recording System Standard Special
Technical Committee
AGENCY:
DEPARTMENT OF JUSTICE
The company plans to import small
quantities of the above listed controlled
substances for non-clinical, laboratorybased research only.
In reference to drug code 7360
(Marihuana), the company plans to
import synthetic cannabinoid agonists.
In reference to drug code 7370
(Tetrahydrocannabinols), the company
will import a synthetic Delta–9–THC.
No other activity for these drug codes
are authorized for this registration.
Any bulk manufacturer who is
presently, or is applying to be,
registered with DEA to manufacture
such basic classes of controlled
substances may file comments or
objections to the issuance of the
proposed registration and may, at the
same time, file a written request for a
hearing on such application pursuant to
21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such comments or objections
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 11, 2010.
This procedure is to be conducted
simultaneously with, and independent
of, the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substances in schedule I
or II are, and will continue to be,
required to demonstrate to the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a); 21 U.S.C. 823(a); and 21
VerDate Nov<24>2008
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
65789
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on September 28,
2009, Cedarburg Pharmaceuticals, Inc.,
870 Badger Circle, Grafton, Wisconsin
53024, made application by renewal to
the Drug Enforcement Administration
(DEA) as a bulk manufacturer of the
basic classes of controlled substances
listed in schedules I and II:
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
I
I
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
In reference to drug code 7370 the
company plans to bulk manufacture a
synthetic Tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than February 9, 2010.
Dated: December 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E9–29527 Filed 12–10–09; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
National Institute of Justice.
ACTION: Notice of request for proposals
for certification and testing expertise.
SUMMARY: The National Institute of
Justice (NIJ) is in the process of
developing a new Vehicular Digital
Multimedia Evidence Recording System
Standard and corresponding
certification program requirements. This
work is being performed by a Special
Technical Committee (STC), comprised
of practitioners from the field,
researchers, testing experts, certification
experts, and representatives from
stakeholder organizations. It is
anticipated that the STC members will
participate in six 2-day meetings over a
9-month time period with the goal of
completing development of the standard
and certification program requirements.
It is anticipated that STC meetings will
begin in mid-January 2010. Travel
expenses and per diem will be
reimbursed for all STC meetings;
however, participation time will not be
funded.
NIJ is seeking representatives from (1)
certification bodies and (2) test
laboratories with experience in
programs for similar types of electronic
equipment. Additional preferred
knowledge includes experience with incar video systems or experience with
law enforcement operations. There are
up to four positions to be filled on the
STC, and NIJ will accept the first 20
submissions for review.
Interested parties are requested to
nominate individuals from their
organizations and submit no more than
two pages describing the nominee’s
applicable experience, preferred
knowledge, and affiliations with
standards development organizations.
This information shall be submitted to
Frances Scott at frances.scott@usdoj.gov
by December 22, 2009. The submissions
will be reviewed, and participants will
be notified regarding their acceptance
by January 8, 2009.
FOR FURTHER INFORMATION CONTACT:
Casandra Robinson by telephone at 202–
305–2296 [Note: this is not a toll-free
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 74, Number 237 (Friday, December 11, 2009)]
[Notices]
[Pages 65788-65789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-29542]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in schedule I or II, and prior to issuing a
regulation under 21 U.S.C. 952(a)(2), authorizing the importation of
such a substance, provide manufacturers holding registrations for the
bulk manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on October 20, 2009, Tocris Cookson, Inc., 16144 Westwoods
Business Park, Ellisville, Missouri 63021-4500, made application
[[Page 65789]]
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled substances
listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Marihuana (7360)........................... I
Tetrahydrocannabinols (7370)............... I
4-Bromo-2, 5-dimethoxyamphetamine.......... I
(7391).....................................
3, 4-Methylenedioxymethamphetamine......... I
(7405).....................................
Amphetamine (1100)......................... II
Phencyclidine (7471)....................... II
Cocaine (9041)............................. II
Diprenorphine (9058)....................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import small quantities of the above listed
controlled substances for non-clinical, laboratory-based research only.
In reference to drug code 7360 (Marihuana), the company plans to
import synthetic cannabinoid agonists. In reference to drug code 7370
(Tetrahydrocannabinols), the company will import a synthetic Delta-9-
THC. No other activity for these drug codes are authorized for this
registration.
Any bulk manufacturer who is presently, or is applying to be,
registered with DEA to manufacture such basic classes of controlled
substances may file comments or objections to the issuance of the
proposed registration and may, at the same time, file a written request
for a hearing on such application pursuant to 21 CFR 1301.43 and in
such form as prescribed by 21 CFR 1316.47.
Any such comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 11, 2010.
This procedure is to be conducted simultaneously with, and
independent of, the procedures described in 21 CFR 1301.34(b), (c),
(d), (e), and (f). As noted in a previous notice published in the
Federal Register on September 23, 1975, (40 FR 43745-46), all
applicants for registration to import a basic class of any controlled
substances in schedule I or II are, and will continue to be, required
to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the
requirements for such registration pursuant to 21 U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: December 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-29542 Filed 12-10-09; 8:45 am]
BILLING CODE 4410-09-P
